Diversified chemicals producers saw reduced sales in Q1 2009 except for DuPont, which was up on the last quarter of 2008. All the companies, however, had sales well down on Q1 2008. Ann McRae, Lambro...
Three of our set of speciality producers (Lubrizol, Nalco and Olin) continues to perform as though there was no global economic downturn at all! Other companies, however, were not so successful. Ann ...
Following the takeover of Nova Chemical by IPIC during the second quarter, this company appears to have ceased publishing quarterly results.
The diversified producers have not as yet shown the same improvement in performance that was noted with the petrochemicals and polymers manufacturers (C&I 2009, 1, 9). With the exception of Solvay, al...
Dow Chemical saw its Q2 2009 sales drop 31% from the Q2 2008 figure, to reach $11.3bn, resulting in a net loss from continuing operations of $435m, compared with a net income of $776m in 2008. Neil E...
‘The excellent results for Q2 and H1 clearly represent how Bristol-Myers Squibb is rapidly transforming into a next-generation biopharma leader through robust science, superior operational performance...
Revenues at German pharma major Merck remained steady at €1.9bn in Q2 and €3.8bn for the first half of 2009, although EBIT fell by 42.4% and 53.9%, respectively.
Improvements in sales volumes were recorded in Q2 2009 by French chemical majors, but there is still a long way to go to return to the levels of 2008. Rhodia, for example, reported a lower year-on-year volume decline: 20% in Q2, compared with 27% in Q1 2009.